Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) EPS (Basic) (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed EPS (Basic) for 3 consecutive years, with -$0.61 as the latest value for Q1 2026.

  • Quarterly EPS (Basic) rose 51.2% to -$0.61 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$3.32 through Jan 2026, up 30.54% year-over-year, with the annual reading at -$5.13 for FY2025, 1.18% down from the prior year.
  • EPS (Basic) for Q1 2026 was -$0.61 at Kestra Medical Technologies, up from -$0.64 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.5 in Q3 2025, with the low at -$1.57 in Q2 2025.
  • Average EPS (Basic) over 3 years is -$1.03, with a median of -$1.18 recorded in 2024.
  • Peak annual rise in EPS (Basic) hit 55.36% in 2025, while the deepest fall reached 28.69% in 2025.
  • Over 3 years, EPS (Basic) stood at -$1.19 in 2024, then skyrocketed by 46.22% to -$0.64 in 2025, then grew by 4.69% to -$0.61 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.61, -$0.64, and -$0.5 for Q1 2026, Q4 2025, and Q3 2025 respectively.